Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

A prospective, controlled, randomized, double blind, 2-arms, parallel-group, multicentre, phase 3 study to investigate effectiveness of Acti… Pending

2024-516284-90-00 rhinosinusitis not requiring antibiotic therapy 5
Efficacy and safety of anakinra in non-COVID-19 related ARDS. ESKA study. Pending

2024-518125-15-00 Acute respiratory distress syndrome (ARDS) 4
Inhaled corticosteroids in young children with episodic wheezing: a multicenter cluster RCT Pending

2025-522694-11-00 Episodic expiratory wheezing 6
Randomized controlled trial comparing immediate versus extended release tacrolimus; reducing calcineurin inhibitor related toxicity in lung … Pending

2024-518639-12-00 lung transplantation 5
Clinical study for patients aged between 6 and 11 years, suffering from non-streptococcal pharyngotonsillitis, who will take the marketed dr… Pending

2025-521526-15-00 NON STREPTOCOCCAL PHARYNGOTONSILLITIS 6
A Phase 2, monocentric, prospective, nonrandomized, open-label, experimental study to evaluate efficacy and safety of intrabronchial instill… Pending

2025-523501-15-00 Simple aspergilloma 4
Clinical trial to assess the safety and tolerability of TP-122A for the treatment of ventilator-associated pneumonia. Pending

2025-521533-85-00 Ventilator-Associated Pneumonia 7
Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR) Pending

2024-512763-32-00 Patients diagnosed at the study sites with rifampicinre 5
The RAPID-Elapse study: Can the drug bupropion improve fatigue symptoms in patients with long COVID? Pending

2025-524443-12-00 Post Covid Syndrome (PCS) 4
The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATI… Pending

2024-518692-56-00 Pregnant 6
Aspirin in acute pneumonia in the elderly: a multicenter, double-blind, randomized, placebo-controlled trial Pending

2024-510811-32-00 acute pneumonia 5
A Phase 1 Study of AIR-001 in Adults with AATD. Pending

2025-523558-14-00 Alpha-1 Antitrypsin Deficiency 1
A single arm phase II study evaluating intracranial efficacy of tarlatamab in patients with asymptomatic active brain metastases from small … Pending

2025-522162-75-00 patients with asymptomatic active brain metastases from 4
The effect of Broncho-Vaxom on the COPD exacerbations in terms of lung function, lung mechanics, immune state, body composition, quality of … Pending

2025-524501-32-02 COPD exacerbation 6
A study to evaluate the efficacy, immunogenicity, and safety of an RSV and hMPV VLP vaccine compared with placebo in participants aged 60 ye… Pending

2024-513740-28-00 Respiratory Syncytial Virus and Human Metapneumovirus 5
Low-dose versus standard-dose anticoagulation with argatroban or enoxaparin during extracorporeal membrane oxygenation controlled by anti-II… Pending

2025-524553-13-00 lung and/or heart failure 4
TRALULALA-AZI Pending

2024-518730-88-00 Chronic Atelectasis 6
Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV immunisation adaptive platform trial (PIPELINE-RSV) Pending

2025-522194-11-00 Respiratory Syncytial Virus (RSV) 5
Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases Pending

2025-522834-30-01 Idiopathic inflammatory myopathy (IIM) 4
Vitamin D as add-on treatment option of pneumonia and sepsis in elderly subjects (TreatViD) Pending

2024-515978-27-00 Sepsis 11
Efficacy of an anti-TSLP monoclonal antibody in the management of chronic bronchial disease induced by bronchiolitis obliterans syndrome in … Pending

2024-516796-33-00 The medical condition studied in IMMUNO-BOS is Bronchio 4
Cysteamine in association with standard therapy for the treatment of hospitalized patients with COVID-19 pneumonia: phase 2 study on safety … Pending

2024-516800-40-00 Infectious diseases of respiratory system (COVID-19) 4
A Phase II, Open-Label, Single Arm, prospective, multicenter study of niraparib plus dostarlimab in patients with pleural mesothelioma posit… Pending

2024-515555-38-01 NON SMALL CELL LUNG CANCER 4
A study to find an efficacious and safe dose of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis Pending

2024-514246-37-00 Idiopathic pulmonary fibrosis (IPF) 4